An international group of researchers from the University of Maryland (United States) and the Institute for Bioengineering of Catalonia (IBEC) led by ICREA Research Professor Silvia Muro, has identifi...
Read moreThe company Chemotargets –based in the Barcelona Science Park and a leader in in the global market as a provider of intelligence and drug design prediction platform– has signed a strategic agreeme...
Read moreAccure Therapeutics, a new pharma R&D player in the Central Nervous System (CNS) field, announces today its launch with a Series A round of funding totalling €7.6 million ($8.1M). The funding round ...
Read moreSOM Biotech reoriented its capabilities to search for the treatments of COVID-19. Raúl Insa, CEO of SOM Biotech, acknowledges that he had never thought of using his technology to find treatment fo...
Read moreTo bring your biologic to market as quickly as possible, streamlined scale up is essential. By combining standardized, single-use platform technologies that can be customized to your particular proces...
Read moreChemotargets -a global leader in the development of intelligence platforms and drug design prediction, headquartered in the Barcelona Science Park- has signed a license agreement for its CLARITY® pla...
Read moreThere are currently more than 10,000 scientific articles related to coronavirus infections. In fact, in recent weeks, research to combat COVID-19 has accelerated, and more than 4,000 new academic pape...
Read moreClinical research is a collaborative process carried out by multidisciplinary teams with the technical and logistic support of all staff from the Barraquer Ophtalmology Center
Read moreResearchers at IBEC and ICMAB develop a flexible, cheap and biocompatible transistor platform able to record an electrocardiogram of cells and micro-tissues during long periods of time.
Read moreResearchers at Bellvitge Biomedical Research Institute will develop a research project with the company Pharmacelera to look for new molecules that block the cohesin complex, with applications in seve...
Read moreDr. Antonio Juárez signed his first knowledge transfer contract thirty years ago, and since then he has continued to collaborate with companies and institutions in the field of microbiology. Now his ...
Read moreIDIVAL researchers belonging to the group of Epidemiology and Pathogenic and Molecular Mechanisms of Infectious Diseases and Microbiology led by Dr. Carmen Fariñas, head of the Infectious Se...
Read more